Cargando…
Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high ‘life threat’ impact cardiopathy
This Phase II study assessed feasibility and efficacy of a biweekly R-COMP-14 regimen (rituximab, cyclophosphamide, non-pegylated liposome-encapsulated doxorubicin, vincristine and prednisone) in untreated elderly patients with poor-risk diffuse large B-cell lymphoma (DLBCL) and moderate to high ‘li...
Autores principales: | Corazzelli, Gaetano, Frigeri, Ferdinando, Arcamone, Manuela, Lucania, Anna, RosariaVilla, Maria, Morelli, Emanuela, Amore, Alfonso, Capobianco, Gaetana, Caronna, Antonietta, Becchimanzi, Cristina, Volzone, Francesco, Marcacci, Gianpaolo, Russo, Filippo, De Filippi, Rosaria, Mastrullo, Lucia, Pinto, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258483/ https://www.ncbi.nlm.nih.gov/pubmed/21707585 http://dx.doi.org/10.1111/j.1365-2141.2011.08786.x |
Ejemplares similares
-
Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas
por: Corazzelli, Gaetano, et al.
Publicado: (2011) -
Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non‐germinal centre B‐cell‐like diffuse large B‐cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial
por: Zhu, Jun, et al.
Publicado: (2022) -
Atrial cardiopathy and stroke
por: Elkind, Mitchell S. V.
Publicado: (2022) -
Successful treatment of an adult with Kasabach-Merritt syndrome using thalidomide, vincristine, and prednisone
por: Huang, Yue-Hua, et al.
Publicado: (2019) -
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study
por: Ayala, Rosa, et al.
Publicado: (2023)